版本:
中国

BRIEF-Ra Pharmaceuticals reports Q3 loss per share $14.22

Nov 29 Ra Pharmaceuticals Inc

* Ra Pharmaceuticals reports third quarter 2016 financial results and provides corporate update

* Q3 loss per share $14.22

* Q3 earnings per share view $-0.72 -- Thomson Reuters I/B/E/S

* On track to initiate phase 2 clinical trial of ra101495 in q1 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐